In type 2 diabetes, the incretin effect (the enhanced insulin response to oral versus intravenous glucose) is reduced
We start with the patient: weight history, prior attempts, family history, blood pressure, glucose, cholesterol, liver markers, sleep, medications, mental health, alcohol use, menopause or PMOS context when relevant, and what the patient is actually trying to accomplish
In phase 2 trials, people were tested at doses of 1 mg, 4 mg, 8 mg, and 12 mg, given weekly
HEPATOBILIARY ADVERSE EFFECTS Evidence based on recent studies Acute pancreatitis following exenatide administration has been documented in case reports since 2006 [50]
If it gets approved in the future, weight loss results from this drug can still look different depending on lifestyle changes, starting point, and individual response
Like nausea, diarrhea may improve over time with continued use of the medication